Sažetak sa skupa
DIFFERENCES IN DRUG CONSUMPTION BETWEEN CITY OF ZAGREB AND POŽEGA-SLAVONIA COUNTY FROM 2010 TO 2017
Deni Rkman
; Medicinski fakultet Sveučilišta u Zagrebu, Hrvatska
Igor Radanović
; Medicinski fakultet Sveučilišta u Zagrebu, Hrvatska
Robert Likić
; Medicinski fakultet Sveučilišta u Zagrebu, Hrvatska; Klinički bolnički centar Zagreb, Klinika za unutarnje bolesti, Zavod za kliničku farmakologiju, Hrvatska
Sažetak
Introduction: Rational drug consumption is essential for a sustainable and efficient health system. By monitoring drug consumption trends, we can analyze and evaluate the state of a particular group of drugs.
Aim: The aim of this paper was to compare drug consumption in the City of Zagreb and Požega-Slavonia County and analyze the differences in consumption.
Methods: Data were acquired from the Agency for Medicinal Products and Medical Devices of Croatia (HALMED). We analyzed the consumption of drugs according to The Anatomical Therapeutic Chemical (ATC) Classification System and expressed in the defined daily doses per 1000 inhabitants per day (DDD/1000/day) and money (HRK). The following groups of drugs were analyzed: drugs affecting the alimentary tract and metabolism (ATC group A), cardiovascular system (ATC group C), antiinfectives for systemic use (ATC group J) and drugs affecting the respiratory system (ATC group R).
Results: City of Zagreb documented a rise in the consumption of drugs that affect alimentary tract and metabolism, from 118.10 DDD in 2010 to 179.39 DDD in 2017. In terms of money, consumption increased from HRK 105,062,656 to HRK 135,642,231. During the same period, in the Požega-Slavonia County, there was a decrease in consumption of the same drug group from 158.72 DDD to 130.49 DDD. Expressed in HRK, a decrease from HRK 8,768,315 to HRK 8,013,176 was recorded. In the City of Zagreb, from 2010 to 2017, there was a slight decrease in the consumption of drugs that affect the cardiovascular system, from 368.44 DDD to 354.07 DDD. In financial terms, there was a cost reduction from HRK 174,866,121 to HRK 138,363,227. In the same period, consumption in Požega-Slavonia County decreased from 518.77 DDD to 249.97 DDD. In Croatian kunas, the cost decreased from HRK 14,873,979 to HRK 10,114,315. The consumption of antiinfectives for systemic use remained stable over the observed time period in the City of Zagreb –21.59 DDD in 2010 to 22.93 DDD to 2017. However, the financial burden increased significantly from HRK 40,579,840 to HRK 114,858,971 respectively. In the County of Požega-Slavonia the consumption and cost were reduced almost 50%, from 26.06 DDD to 18.14 DDD and from 3.153.539 HRK to 1.888.795 HRK respectively. In the City of Zagreb there was an increase in the consumption of drugs affecting the respiratory system, from 55.59 DDD to 64.65 DDD. Converted into money, consumption increased from HRK 60,643,520 to HRK 67,842,946. County of Požega-Slavonia recorded a decrease in consumption of the same drug group from 64.23 DDD to 53.69 DDD and from 4.682.399 HRK to 3.9221.239 HRK respectively.
Conclusion: The City of Zagreb documented an increase in consumption in 3 groups of drugs, both in DDD and HRK. Only the consumption of drugs affecting the cardiovascular system was reduced. On the other hand, Požega-Slavonia County decreased consumption in all 4 groups of drugs in both parameters. In 2010, the consumption of all 4 ATC drug groups in Požega-Slavonia County expressed in DDD was higher than in the City of Zagreb, while in 2017 it was lower in all analyzed groups.
Ključne riječi
Hrčak ID:
218620
URI
Datum izdavanja:
31.12.2018.
Posjeta: 853 *